Investment
Features
FeesSafety
Academy
More
Pluang+

Compare DexCom, Inc. (DXCM) vs 10X Genomics Inc (TXG) Price & Performance

DexCom, Inc.Trade
10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

DexCom, Inc. vs 10X Genomics Inc — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while 10X Genomics Inc trades at $58.56 (market cap $7.61B). The key difference: DexCom, Inc. is far larger — about 4.4× 10X Genomics Inc's market cap. Which is the better fit depends on your goals.

DXCMTXG
Market Cap
$33.79B$7.61B
Sector
HealthHealth
52-Week High
$89.53$58.57
52-Week Low
$54.84$11.34
Enterprise Value
$33.24B$7.14B

Returns comparison

Trailing returns across standard periods

About DexCom, Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.

Read more on DXCM

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG